Investigational Drug Information for KBP-5074
✉ Email this page to a colleague
What is the development status for investigational drug KBP-5074?
KBP-5074 is an investigational drug.
There have been 9 clinical trials for KBP-5074.
The most recent clinical trial was a Phase 2 trial, which was initiated on November 10th 2021.
The most common disease conditions in clinical trials are Renal Insufficiency, Chronic, Kidney Diseases, and Hypertension. The leading clinical trial sponsors are KBP Biosciences, Covance, and Medpace, Inc.
Summary for KBP-5074
| US Patents | 0 |
| International Patents | 16 |
| US Patent Applications | 8 |
| WIPO Patent Applications | 3 |
| Japanese Patent Applications | 3 |
| Clinical Trial Progress | Phase 2 (2021-11-10) |
| Vendors | 12 |
Recent Clinical Trials for KBP-5074
| Title | Sponsor | Phase |
|---|---|---|
| Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe CKD | KBP Biosciences | Phase 3 |
| Mass Balance Study of KBP-5074 in Healthy Male Subjects | Covance | Phase 1 |
| Mass Balance Study of KBP-5074 in Healthy Male Subjects | KBP Biosciences | Phase 1 |
Clinical Trial Summary for KBP-5074
Top disease conditions for KBP-5074
Top clinical trial sponsors for KBP-5074
US Patents for KBP-5074
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for KBP-5074
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| KBP-5074 | Canada | CA2808678 | 2030-08-18 | ⤷ Subscribe |
| KBP-5074 | China | CN102372710 | 2030-08-18 | ⤷ Subscribe |
| KBP-5074 | China | CN103547577 | 2030-08-18 | ⤷ Subscribe |
| KBP-5074 | Denmark | DK2607363 | 2030-08-18 | ⤷ Subscribe |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
